TrialPloS one2015

A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis.

James G Krueger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.